Sort by
Medicine and Dentistry
Child Health
100%
Pneumococcus Vaccine
56%
Human Immunodeficiency Virus
50%
Disease
42%
Pathogen
41%
Streptococcus Pneumoniae
36%
Pneumococcal Infection
34%
Toddlers
29%
Human Respiratory Syncytial Virus
27%
Case-Control Study
27%
Serotype
25%
Thorax Radiography
24%
Systematic Review
23%
Cohort Effect
23%
Induced Sputum
21%
Chest Radiograph
20%
Low and Middle Income Countries
18%
Health Care Cost
17%
Household
17%
COVID-19
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Polymerase Chain Reaction
16%
Meningitis
15%
Prevalence
14%
Infection
14%
Pneumococcal Pneumonia
13%
Respiratory Tract Infection
13%
Cost-Effectiveness Analysis
12%
Pneumococcus
12%
Haemophilus Influenzae Type B
11%
Odds Ratio
11%
Pediatric Pneumonia
11%
Community-Acquired Pneumonia
10%
Haemophilus influenzae
10%
Upper Respiratory Tract
9%
Diagnosis
9%
Human Metapneumovirus
9%
Disease Burden
9%
Pneumococcal Meningitis
9%
Wheeze
9%
Symptom
8%
Childhood Mortality
8%
Pneumocystis Pneumonia
8%
Human Immunodeficiency Virus Infection
8%
Lung Aspiration
8%
Case Fatality Rate
7%
Vaccine
7%
Staphylococcus Aureus
7%
Decision Making
7%
Blood Culture
6%
Keyphrases
Pneumonia Etiology Research for Child Health
65%
Pneumonia
58%
Health Studies
51%
Pneumococcal Conjugate Vaccine
34%
Pneumonia Etiology
28%
COVID-19
26%
Streptococcus Pneumoniae
25%
Young children
22%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
22%
HIV Patients
20%
World Health Organization
20%
Etiology
20%
Gambia
19%
Childhood Pneumonia
19%
Respiratory Syncytial Virus
19%
Invasive Pneumococcal Disease
19%
Credible Interval
18%
Very Severe Pneumonia
16%
PCV10
15%
Neutralizing Antibodies
15%
Severe Pneumonia
15%
Polymerase Chain Reaction
14%
Immunogenicity
14%
Dosing Schedule
13%
Chest Radiograph
13%
Bangladesh
13%
Induced Sputum
13%
Disease Burden
10%
China
10%
Community Control
10%
Epidemiology
10%
Nasopharyngeal
10%
Immunization
10%
Low-middle Income Countries
9%
Revaccination
9%
Acute Lower Respiratory Infection
9%
Population-based Surveillance
9%
Adjusted Odds Ratio
8%
Vaccine Effectiveness
8%
Confidence Interval
8%
Meta-analysis
8%
Haemophilus Influenzae Type b
8%
Nasopharyngeal Swab
8%
Antibody Response
8%
Mycobacterium Tuberculosis (M. tb)
8%
COVID-19 Vaccine
7%
All Ages
7%
Pneumococcus
7%
Wheezing
7%
Antiretroviral Therapy
7%